Clinical Trials Access Collaborative (CTAC) is a partnership committed to making medical research more accessible.
Clinical trials are a crucial component to advancing medical research and improving patient outcomes. By expanding participation in clinical trials, communities across the U.S. will have the opportunity to participate in and benefit from the latest advancements in treatment while improving medical research.
* CTAC presently is in the 501(c)(3) application process.
Company Details
- Employees
- 1
- Address
- Barriers That Prevent Communities Of Color And Other Underrepresented Groups From Participating In And Benefiting From The Development Of Life-Saving Medical Treatments.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://ctac.org
Clinical Trials Access Collaborative (Ctac) Questions
Clinical Trials Access Collaborative (Ctac)'s website is https://ctac.org
Clinical Trials Access Collaborative (Ctac)'s LinkedIn profile is https://www.linkedin.com/company/clinicaltrialsaccesscollaborative
Clinical Trials Access Collaborative (Ctac) has
1 employees.
View email and phone details for 1
employees at Clinical Trials Access Collaborative (Ctac).
Clinical Trials Access Collaborative (Ctac)'s industry is
Biotechnology Research
Clinical Trials Access Collaborative (Ctac)'s top competitors are
Phrma,
Association For Hospital Medical Education,
Cliniphai,
Pi Health Sciences Ltd,
Endpoint Clinical,
Linear Clinical Research,
Society For Clinical Research Sites (Scrs),
Adamdanyal.com,
Amgen.
Clinical Trials Access Collaborative (Ctac)'s categories are Biotechnology Research
